Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI chatbot aims to tackle America's sleep crisis

NCT ID NCT07718750

Symptom relief Sponsor: New York University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a two-week AI chatbot program can improve sleep in adults who struggle with sleep problems. Participants use the chatbot on their smartphone to receive personalized sleep education and skills. The study measures changes in sleep duration, how quickly people fall asleep, and sleep efficiency using a Fitbit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an AI-based chatbot that delivers personalized sleep education and skills
What this could lead to
If effective, this low-cost chatbot could offer a widely accessible tool for improving sleep in adults.
What could go wrong
This is a small, early-stage trial with 60 participants. The chatbot's effects may not generalize to everyone, and it relies on self-reported and Fitbit data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18-75 years * had a raw score of 23 or higher on the Patient-Reported Outcomes Measurement Information System (PROMIS™) Sleep Disturbance * had a smartphone and be able to access the internet * willing and able to participate through text messages on a smartphone * able to read and understand English Exclusion Criteria: * pregnant or lactating * concurrently participating in other research studies focused on lifestyle modifications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep problems are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parasomnias

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep problems

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • New York University

    COMPLETED

    New York, New York, 10010, United States

  • New York University

    RECRUITING

    New York, New York, 10010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.